29 C
Vientiane
Wednesday, April 30, 2025
spot_img
Home Blog Page 243

MyRepublic Launches Industry-First Gamified Customer Experience with Pocket Rocket Adventures


SINGAPORE – Media OutReach Newswire – 4 April 2025 – MyRepublic, one of Asia-Pacific’s leading digital-first telcos, announced the launch of Pocket Rocket Adventures, an industry-first initiative that introduces unique gamification mechanics into the customer experience journey for their broadband and mobile subscribers. The game, accessible via the MyRepublic mobile app available from April, marks a significant step in the company’s broader strategy to drive engagement, loyalty, and long-term customer value through innovative, non-traditional channels.

Pocket Rocket Adventures
Pocket Rocket Adventures

In Pocket Rocket Adventures, subscribers participate in an idle-style space-themed game that rewards play time with prizes from MyRepublic swag to gaming consoles. Customers progress by upgrading in-game equipment, crafting an army of companions, completing challenges, and participating in seasonal events—earning points, digital rewards, and exclusive merchandise. Longstanding subscribers receive additional in-game rewards for linking their game account to the MyRepublic App, creating a tiered experience based on tenure and engagement.

This initiative represents a shift in how telecom operators approach customer retention and lifecycle management. MyRepublic is leveraging game mechanics to create a deeper, more interactive relationship with its customers—blurring the line between service utility and digital experience.

Pocket Rocket Adventures is more than just a game—it’s a strategic extension of how we view customer experience in the digital age,” said Terry Williams, Vice President, Consumer at MyRepublic. “As a digital-native telco, we are constantly exploring new ways to engage our customers. This is an industry-first initiative in Singapore’s telecom sector, where gamification is embedded into our core customer engagement model.”

By integrating gameplay with user milestones, Pocket Rocket Adventures also serves as a data-driven loyalty program, enabling MyRepublic to better understand customer behaviours and preferences across its mobile and broadband segments. Through this model, the company aims to build a long-term digital ecosystem that delivers continuous value beyond connectivity.

“Gamification is no longer just a trend in consumer apps—it’s now a business tool,” added Terry Williams. “We believe telcos need to evolve beyond transactional models and create participatory experiences that are emotionally engaging and memorable. This program is the start of a longer-term transformation in how we design and deliver customer value.”

The move is part of MyRepublic’s broader strategy to differentiate in a competitive market by doubling down on its roots in the gaming community with its new campaign, ‘Geeks Use Us’, while also leading innovation in customer experience transformation. In recent years, the company has invested heavily in digital platforms, automation, and self-service, with Pocket Rocket Adventures serving as a flagship example of how digital engagement can be both scalable and rewarding.

Singaporeans will be able to access the game through the MyRepublic mobile app from April, with MyRepublic customers earning rewards including digital assets, MyRepublic merchandise, and gaming consoles also redeemable through their mobile app.
Hashtag: #PocketRocketAdventure #PRA #MyRepublic #MyRepublicSG #MyRepublicLaunch #PocketRocketByMR





The issuer is solely responsible for the content of this announcement.

MyRepublic Broadband Pte Ltd

MyRepublic is an award-winning telecom operator whose values lie in the future of connectivity, the next opportunity to disrupt, and innovations that will make a real difference. The provider’s priority is to redefine broadband and mobile connectivity in the markets it operates and empower customers to understand what a true modern connectivity experience can be.

Social Media Users Question Government Report Claiming Poverty Eradication in Vientiane

Social Media Users Question Government Report Claiming Poverty Eradication in Vientiane

A recent government report claiming that 99.43 percent of families in Vientiane Capital have been lifted out of poverty has sparked widespread skepticism on social media, with many users reacting with the laughing emoji on several Facebook posts.

Li Ka Shing Foundation and Temasek Trust Jointly Commit S$12 Million to Acquire Systems and Advance Clinical Trial for Innovative Histotripsy Cancer Therapy in Singapore

  • Li Ka Shing Foundation (LKSF) and Temasek Trust (TT) are purchasing and donating two Histotripsy Systems to the National Cancer Centre Singapore (NCCS) and the National University Cancer Institute, Singapore (NCIS) in Singapore to perform clinical trials to study novel ultrasound therapy for liver, kidney and pancreatic cancers.
  • The funding from LKSF and TT will be disbursed through a Donor-Advised Fund managed by TT Foundation Advisors (TTFA), which catalyses additional capital from other donors to support cancer research.

SINGAPORE – Media OutReach Newswire – 04 April 2025 – The Li Ka Shing Foundation (LKSF) and Temasek Trust (TT) have committed S$12 million to bring innovative non-invasive ultrasound-based histotripsy tumour clinical trials to Singapore.

The National Cancer Centre Singapore (NCCS) and the National University Cancer Institute, Singapore (NCIS) will each receive one Histotripsy System – the first of such to be available in Southeast Asia. The funding from LKSF and TT will also support a clinical trial in Singapore for patients with liver, kidney, and pancreatic cancers, advancing regional cancer research and innovation.

Mr. Dickson Lim, Head, TTFA, said, “We at TTFA are delighted to have the Li Ka Shing Foundation and Temasek Trust come together to catalyse this important initiative, to study this innovative non-invasive ultrasound-based cancer therapy in Southeast Asia. We are privileged to work alongside NCCS and NCIS to support clinical research and trials to use this novel modality that targets important cancers. Over time, we aim to attract additional philanthropic capital from other donors to sustainably support the next phase of cancer research.”

Rising Regional Cancer Burden and the Need for Innovative Treatment

Liver, kidney, and pancreatic cancers are on the rise across Asia, with Southeast Asia experiencing the fastest-growing incidence and mortality rates. Factors such as aging populations, changing lifestyles, and environmental exposure contribute to the regional cancer burden. In Singapore, liver cancer is the third most common cause of cancer death for men, with liver and pancreatic cancers among the top 10 causes of cancer mortality. These cancers often do not show symptoms until the later stages, making early detection and effective treatment difficult.

Histotripsy: An Innovative Technology

Developed by US medical company, HistoSonics, the HistoSonics Histotripsy System generates microbubbles that rapidly expand and collapse, producing shock waves that break down tumours at the cellular level. This approach does not require surgery, and can non-invasively destroy tumours, including those that cannot be surgically removed.

Unlike surgery, radiotherapy, or traditional ablation, histotripsy requires no incisions or radiation, offering a painless, scarless, and bloodless treatment.

Clinical Trial on Histotripsy Therapy and Research in Asia

The application for the clinical trial using the HistoSonics Histotripsy System is being prepared. Professor Brian Goh Kim Poh, Head of Hepatopancreatobiliary and Transplant Surgery, NCCS and Singapore General Hospital, and principal investigator of the trial, will work alongside a team of oncologists, interventional radiologists and researchers from both NCCS and NCIS.

Professor Goh said, “We are excited to have the opportunity to embark on clinical trials for liver, kidney and pancreatic cancers which are prevalent in Southeast Asia. We plan to initiate trials for liver cancers first. While surgery and local ablative therapies are the main treatment modalities for liver cancers today, not all patients are suited to undergo these invasive treatments due to various factors such as patient fitness, tumour location or underlying liver disease. For these patients, innovations such as histotripsy offer an alternative option with potential advantages as it is non-invasive. We are extremely grateful to the Li Ka Shing Foundation and Temasek Trust for their generosity and strong support towards advancing cancer research by enabling us to study this novel technology.”

Associate Professor Glenn Kunnath Bonney, Senior Consultant, Division of Surgical Oncology, NCIS, said: “We are currently preparing for the clinical trial of histotripsy as a potential treatment approach for patients with liver and other complex cancers. I have just returned from an international meeting where I was shown the promising results from early clinical trials. This initiative reflects our ongoing commitment to expanding evidence-based options through rigorous research, with the goal of improving patient outcomes over time. We are grateful to the Li Ka Shing Foundation and Temasek Trust for their support, and look forward to working with our partners to build the necessary foundation for careful clinical studies.”

The clinical trial is slated to commence later this year, with a targeted enrolment of 40 patients who meet the trial criteria and are reviewed by a multi-disciplinary team.

Ensuring Sustainable Impact through Strategic Philanthropy

To drive long-term impact in the region, the funding from LKSF and TT will be disbursed through a Donor-Advised Fund (DAF) managed by TTFA, the philanthropy advisory services arm of TT. Through the DAF, TTFA aims to attract additional capital from other donors over time to sustainably support the next phase of cancer research.

Hashtag: #LiKaShingFoundation #TemasekTrust

The issuer is solely responsible for the content of this announcement.

About Li Ka Shing Foundation

Li Ka Shing Foundation believes in philanthropy with societal impact. Since 1980, we have been helping to reform education and further medical research. To date, Mr Li Ka-shing has invested over HK$30 billion in projects covering education, medical services, charity and anti-poverty programmes, with about 80% of the projects in Mainland China and Hong Kong.

About Temasek Trust

Temasek Trust was established by Temasek Holdings and is a steward of philanthropic assets. It aims to catalyse positive impact by protecting the planet, uplifting communities, connecting people, and advancing capabilities. By forging new pathways for philanthropy and impact investing with like-minded partners, Temasek Trust seeks to promote catalytic philanthropy as a force for good. For more information, visit . Follow us on , , , and .

About TT Foundation Advisors (TTFA)

TT Foundation Advisors is an independent professional philanthropy services advisory arm of Temasek Trust. It provides specialised philanthropy advisory and management services to philanthropic foundations, family offices, business corporations, philanthropists, and charities. It taps on Temasek Trust’s insights, capabilities, and resources, as well as the expertise and evidence-based interventions across the wider philanthropic ecosystem, to deliver strategic and impactful solutions for its clients.

About National Cancer Centre Singapore (NCCS)

The National Cancer Centre Singapore (NCCS) is a leading national and regional tertiary cancer centre with specialists who are experts in treating cancer. In addition to offering holistic and multidisciplinary oncology care, our clinicians and scientists collaborate with local and international partners to conduct robust, cutting-edge clinical and translational research. To achieve its vision of being a global leading cancer centre, NCCS offers world-class care and shares its depth of experience and expertise by training local and overseas medical professionals.

To meet growing healthcare needs, the new NCCS building opened in 2023 with increased capacity and expanded facilities dedicated to cancer care, rehabilitation, research and education. To give patients the best treatment outcomes, advanced and innovative treatment such as proton therapy is offered at the new Goh Cheng Liang Proton Therapy Centre at NCCS. For more information, please visit

About National University Cancer Institute, Singapore (NCIS)

The National University Cancer Institute, Singapore (NCIS) is an academic, national specialist centre for cancer under the National University Health System (NUHS), and is the only public cancer centre in Singapore that treats both paediatric and adult cancers in one facility.

As one of two national cancer centres in Singapore, NCIS (pronounced as “n-sis”) offers a broad spectrum of cancer care and management from screening, diagnosis and treatment to rehabilitation and survivorship, as well as palliative and long-term care. NCIS’ strength lies in the multidisciplinary approach taken by our clinician scientists and clinician-investigators to develop a comprehensive and personalised plan for each cancer patient.

NCIS provides the full suite of specialised oncology and haematology services at the NUH Medical Centre at Kent Ridge, Singapore, including those by the NCIS Chemotherapy Centre, NCIS Radiotherapy Centre and NCIS Cellular Therapy Centre.

NCIS also offers cancer services at other hospitals in Singapore:
* NCIS Cancer & Blood Clinic @ Ng Teng Fong General Hospital
* NCIS Radiotherapy Centre @ Tan Tock Seng Hospital
* NCIS Radiotherapy Clinic @ Khoo Teck Puat Hospital

To bring cancer care even closer to our patients, our NCIS on the Go programme delivers a range of cancer services at clinics within the community for their convenience. For more information, please visit .

About HistoSonics

HistoSonics is a privately held medical device company developing non-invasive platforms and proprietary sonic beam therapy utilizing the science of histotripsy, a novel mechanism of action that uses focused ultrasound to mechanically destroy and liquify unwanted tissue and tumours. The company is currently focused on commercialising their HistoSonics Histotripsy System in the US and select global markets for liver treatment while expanding histotripsy applications into other organs like kidney, pancreas, prostate, brain, and others. HistoSonics has offices in Ann Arbor, Michigan, and Minneapolis, Minnesota.

For more information on the HistoSonics Histotripsy System, please visit: . For patient related information, please visit: .

IBM Tees Up watsonx AI-powered Digital Fan Features for the 2025 Masters Tournament

  • Enhanced Hole Insights offers more detailed analysis around historic, in-Tournament and projected play for every hole on course 
  • AI Narration in English and Spanish returns, along with revamped Masters Tournament app on Apple Vision Pro

ARMONK, N.Y., April 4, 2025 /PRNewswire/ — IBM (NYSE: IBM) and the Masters Tournament today announced a series of digital fan features returning to the award-winning Masters app and Masters.com ahead of this year’s Tournament. The watsonx AI-powered capabilities – the latest in a 30-year collaboration between IBM and the Masters – aim to deliver a more personalized and engaging experience for millions of new and existing golf fans around the world following all the action at the Masters Tournament.

Example of Master's Digital Platform, including IBM Hole Insights
Example of Master’s Digital Platform, including IBM Hole Insights

More strategic shot analysis with Hole Insights 2.0
IBM Hole Insights is returning for its second year as part of the Track Shots experience on Masters.com and the Masters app. The AI driven Insights 2.0 leverages watsonx technologies including the Granite LLM to offer data-driven insights around every shot taken on every hole at Augusta National. This includes:

  • Data-driven recaps of how each hole has played daily and throughout the 2025 Tournament (e.g., “No. 14 has played difficult today, with 25% of scores resulting in bogies.”).
  • Projections of how each hole might play, based on past and current performance data (e.g., “No. 9 is projected to be the third most difficult hole today.”).
  • Historical insights into how each hole has played, based on nine years of Tournament data – including more than 180,000 shots – and ball position on course (e.g., “Shots historically hit in this location have an 82% chance of resulting in a birdie.”).

This year, the solution has been built to provide enhanced, more powerful insights. To enhance the quality of the insights, IBM Consulting fine-tuned Granite and other LLMs on a wealth of sources including historic shot locations, insights from golf experts including past Masters Tournament caddies, and Tournament data spanning nine years and more than 180,000 shots. 

Revamped Masters app on Apple Vision Pro
IBM and the Masters are once again giving fans an immersive view of the action with the Masters app on Apple Vision Pro. This year’s updated app offers fans clearer 3D visuals of Augusta National and new features such as Video on Demand. Fans will also experience returning features such as Hole Insights 2.0 and AI Narration.

With the Masters app on Apple Vision Pro, fans can look through different 3D views of each hole, explore the dramatic elevation changes throughout the course, and even watch multiple Tournament live streams simultaneously.

“For more than 30 years, IBM and Augusta National have worked side-by-side to co-create unique digital experiences that bring the beauty, tradition, and excitement of the Masters to millions of golf fans worldwide,” said Jonathan Adashek, Senior Vice President of Marketing and Communications. “This powerful combination of people and technology, including watsonx AI models and agents, is a live case study for businesses across all industries on how they too can unlock the  potential of their data to deliver actionable business insights and exceptional customer experiences.”

The Masters and IBM have partnered for nearly 30 years to transform Masters data into world-class digital experiences for golf fans. This includes launching Masters.com in 1996, AI Highlights, Round in Three Minutes, My Group, Player Insights, AI Narration, Hole Insights, and the Masters app on Apple Vision Pro.

IBM’s partnerships with the Masters and other iconic sporting organizations, including Scuderia Ferrari HP, Wimbledon, the US Open, ESPN Fantasy Football, and UFC, are powered by the same AI and hybrid cloud solutions used by IBM clients across industries to make more informed, data-driven business decisions.

The 89th Masters Tournament will be held from April 10-13 at Augusta National Golf Club in Augusta, GA. Check out all the IBM watsonx technologies in action by visiting Masters.com or the Masters app available on mobile devices, the Apple App Store and the Google Play Store.

About IBM
IBM is a leading provider of global hybrid cloud and AI, and consulting expertise. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain a competitive edge in their industries. Thousands of government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and consulting deliver open and flexible options to our clients. All of this is backed by IBM’s long-standing commitment to trust, transparency, responsibility, inclusivity and service. Visit www.ibm.com for more information.

IBM Media Contact:

Sarah Benchaita
IBM
sarah.benchaita@ibm.com

IBM Corporation logo.
IBM Corporation logo.

 

Easter and School Holiday Escapes, A Family-Friendly Retreat at Sheraton Bali Kuta Resort

BALI, Indonesia, April 4, 2025 /PRNewswire/ — Celebrate Easter and the upcoming school holidays with an unforgettable beachfront getaway at Sheraton Bali Kuta Resort. With a refreshed lobby, a vibrant social lounge at &More by Sheraton, and the newly renovated “PlayHouse” kids club, the resort blends premium comfort with family-friendly fun in the heart of Kuta.

Junior Family Suite at Sheraton Bali Kuta, featuring two separate sleeping areas for comfort and privacy. Parents can unwind in their private king-bedroom, while kids enjoy their sofa bed and fold-out chair—all within a spacious 62 sqm suite.
Junior Family Suite at Sheraton Bali Kuta, featuring two separate sleeping areas for comfort and privacy. Parents can unwind in their private king-bedroom, while kids enjoy their sofa bed and fold-out chair—all within a spacious 62 sqm suite.

Wake up to the gentle sound of waves and breathtaking ocean views from your private balcony, setting the perfect tone for a memorable family escape. The Suite Experience package offers spacious comfort with a sofa bed, kids’ tent amenities, a one-time minibar, VIP perks, and a special family room setup. Begin your day with a lavish buffet breakfast, fueling adventures for the little ones at PlayHouse, where 20+ activities keep them entertained, while parents unwind by the infinity pool or enjoy curated moments with the Side by Side program. Afternoons invite relaxation and indulgence with the Jewelry Box Afternoon Tea, a delightful treat for the whole family. Families can also enjoy 15% off dining, including the famous Sunday Social Brunch, where kids dine free. As the sun sets, the revitalized lobby offers a warm, inviting space for coffee, pastries, and social gatherings, while &More by Sheraton sets the scene for a perfect evening with live music, handcrafted cocktails, and stunning views of Kuta Beach. Savor authentic Italian cuisine at Bene Italian Kitchen, sip signature drinks at &More by Sheraton, or explore diverse culinary delights at Daily Social, all with panoramic ocean vistas. Just steps from Beachwalk Shopping Center, local markets, and the iconic WXYZ Bar at Aloft Bali Kuta, the resort offers the perfect balance of relaxation and excitement. Whether an Easter egg hunt by the beach or a sunset cocktail, every moment is designed for lasting memories. Ashley Lai, Cluster General Manager of Sheraton Bali Kuta Resort & Aloft Bali Kuta at Beachwalk, shares “It’s more than a place to stay, it’s a destination. With refreshed spaces, family-friendly experiences, and unmatched dining, we create moments that last a lifetime.” Enjoy the Marriott Bonvoy Fast Track program, become a member and register by April 14, 2025, to earn 1,000 bonus points and 1 Elite Night Credit per night. For more information visit Sheraton Bali Kuta Resort.

South Korea Court Upholds President Yoon’s Impeachment, Strips Him of Office

Yoon Suk Yeol
Badges and flags are displayed on a table for supporters of South Korea president Yoon Suk Yeol and former president Park Geun-hye, as they gather prior to the announcement of the Constitutional Court's verdict on Yoon's impeachment outside the presidential residence in Seoul on April 4, 2025. (Photo by ANTHONY WALLACE / AFP)

By Hieun Shin and Claire Lee/AFP – South Korea’s Constitutional Court on 4 April upheld President Yoon Suk Yeol’s impeachment over his disastrous martial law declaration, voting unanimously to strip him of office for violating the constitution.

Vientiane Province Steps Up Wildfire Prevention Efforts as Fire Alerts Increase

Phou Phanang National Biodiversity Conservation Area Wildfire (Photo: Somchith Phanthouamath)

Vientiane Province has recorded 385 fire alerts in the first quarter of 2025, signaling an increase in fire activity, according to Global Forest Watch.

NUS researchers combine 3D bioprinting with AI to personalise oral soft tissue grafts

Artificial intelligence streamlines the optimisation of bioprinting parameters for oral soft tissue grafts, reducing time and resource demands while enabling efficient, personalised dental treatments

SINGAPORE, April 4, 2025 /PRNewswire/ — A team of researchers from the National University of Singapore (NUS) has developed a method to fabricate personalised gingival (gum) tissue grafts using an innovative combination of 3D bioprinting and artificial intelligence (AI).

Led by Assistant Professor Gopu Sriram from NUS Faculty of Dentistry, the team’s approach presents a more customisable and less invasive alternative to traditional grafting methods, which often involve harvesting tissue from the patient’s mouth — a process that can be both uncomfortable and constrained by the availability of suitable tissue.

The 3D bioprinting and AI-enabled technique has the potential to address key challenges in dental procedures more effectively, such as repairing gum defects caused by periodontal disease or complications from dental implants. For instance, by enabling the precise fabrication of tissue constructs tailored to individual patients, the method can significantly improve treatment outcomes, reduce patient discomfort, and minimise the risk of complications, such as infections, during recovery.

The team’s research was published in the journal Advanced Healthcare Materials on 17 December 2024, and was supported by grants from National Additive Manufacturing Innovation Cluster (NAMIC) and National University Health System (NUHS).

Turbocharging the bioprinting process with AI

Gum tissue grafts are essential in dental care, particularly for addressing mucogingival defects such as gum recession, and complications arising from periodontal disease or dental implants. Typically, these grafts are harvested from the patient’s mouth. Though effective, these procedures come with significant drawbacks: patient discomfort, limited tissue availability, and a higher risk of postoperative complications.

To overcome these challenges, the researchers turned to 3D bioprinting, a technique that fabricates custom-made tissue grafts tailored to the specific dimensions of each patient’s defect. They developed a specialised bio-ink which supports the growth of healthy cells, while also ensuring the material can be printed accurately and holds its shape and structure.

However, the viability of 3D bioprinting is only as good as the parameters applied during the process. Factors such as extrusion pressure, print speed, nozzle dimensions, bio-ink viscosity and printhead temperature all play a crucial role in determining the final properties and performance of the printed component. Tuning these parameters has traditionally been done through tedious, manual trial-and-error experiments that are extremely time- and resource-consuming.

“To speed up the 3D bioprinting process, we integrated AI into our workflow to address this critical bottleneck,” said Professor Dean Ho, Head of the Department of Biomedical Engineering in the College of Design and Engineering at NUS, and co-corresponding author of the research paper. “This approach greatly streamlines the process by reducing the number of experiments needed to optimise the bioprinting parameters — from potentially thousands to just 25 combinations,” added Prof Ho, who is also Director of the Institute for Digital Medicine (WisDM) at NUS Yong Loo Lin School of Medicine, and N.1 Institute for Health (N.1) at NUS.

This tremendous efficiency boost afforded by the team’s AI-driven workflow saves time and resources while ensuring the creation of tissue constructs with precise dimensions and structural integrity.

“Our study is among the first to specifically integrate 3D bioprinting and AI technologies for the biofabrication of customised oral soft tissue constructs,” said Asst Prof Sriram, who is also the Thrust Co-Lead of Dental and Craniofacial 3DP Applications at NUS Centre for Additive Manufacturing (AM.NUS). “3D bioprinting is by far more challenging than conventional 3D printing because it involves living cells, which introduce a host of complexities to the printing process.”

The bioprinted gum tissue grafts exhibited strong biomimetic properties, maintaining over 90% cell viability immediately after printing and throughout an 18-day culture period. The grafts also retained their shape and structural integrity, while histological analyses confirmed the presence of key proteins and a multi-layered structure closely resembling natural gum tissue.

The future of dental care

In dentistry, the ability to produce personalised gum tissue grafts with improved efficiency, structural integrity, and biomimetic properties could address longstanding clinical challenges associated with periodontal diseases and dental implants. “This research demonstrates how AI and 3D bioprinting can converge to solve complex medical problems through precision medicine,” added Asst Prof Sriram. “By optimising tissue grafts for individual patients, we can reduce the invasiveness of dental procedures while ensuring better healing and recovery.”

Excitingly, the potential implications of this research extend beyond dentistry. “3D bioprinting allows us to create tissue grafts that precisely match the dimensions of a patient’s wounds, potentially reducing or eliminating the need to harvest tissue from the patient’s body,” said Asst Prof Sriram.

“This level of customisation minimises graft distortion and tension during wound closure, reducing the risk of complications, surgery time and discomfort to the patients.” said Dr Jacob Chew, a periodontist, co-investigator of the study, and Academic Fellow at NUS Faculty of Dentistry.

Furthermore, the scarless healing characteristics of oral tissue provide a unique advantage, as insights from this study could inform the fabrication of similar grafts for other barrier tissues, such as skin, potentially aiding in the scarless healing of skin wounds.

Future research will focus on translating these findings from bench to bedside. The team plans to conduct in vivo studies to assess the integration and stability of the grafts in oral environments. They also aim to explore the integration of blood vessels into the grafts through multi-material bioprinting to create more complex and functional constructs. With these developments, the researchers hope to advance the field of regenerative dentistry while paving the way for broader applications in tissue engineering.

Read more at: https://news.nus.edu.sg/combining-3d-bioprinting-with-ai-to-personalise-oral-soft-tissue-grafts.